These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2862931)

  • 1. [Interaction of beta-adrenergic agents with the plasma membranes of the myocardium].
    Chekman IS; Budarin LI; Nurishchenko NE; Ivanov LV; Pogrebnoĭ PV
    Biull Eksp Biol Med; 1985 Aug; 100(8):208-10. PubMed ID: 2862931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors.
    Contreras ML; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Apr; 237(1):154-64. PubMed ID: 2870174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of agonists and antagonists with beta-adrenergic receptors.
    Molinoff PB; Weiland GA; Heidenreich KA; Pittman RN; Minneman KP
    Adv Cyclic Nucleotide Res; 1981; 14():51-67. PubMed ID: 6116391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of beta adrenergic receptor agonists and blockaders on the action of bradykinin].
    Shvarts GIa
    Biull Eksp Biol Med; 1981 Nov; 92(11):575-6. PubMed ID: 6119126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.
    Marsh JD; Smith TW
    Mol Pharmacol; 1985 Jan; 27(1):10-8. PubMed ID: 2981398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of alprenolol on the beta-receptor and adenylate cyclase activity in rabbit heart membranes.
    Tkachuk VA; Wollemann M
    Mol Pharmacol; 1981 Jul; 20(1):224-6. PubMed ID: 6270534
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta adrenergic receptor subtypes in the atria: evidence for close coupling of beta-1 and beta-2 adrenergic receptors to adenylate cyclase.
    Liang BT; Molinoff PB
    J Pharmacol Exp Ther; 1986 Sep; 238(3):886-92. PubMed ID: 2875173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of adrenomimetic, adreno- and ganglionic-blocking agents during hyperbaric oxygenation].
    Filatov AF; Reznikov KM
    Farmakol Toksikol; 1982; 45(2):35-9. PubMed ID: 6122598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. II. Agonist binding to soluble beta adrenergic receptors.
    Contreras ML; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Apr; 237(1):165-72. PubMed ID: 2870175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterisation of -receptor blocking agents.
    Saameli K
    Jpn J Pharmacol; 1972; 22():Suppl22:13. PubMed ID: 4403917
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcellular myocardial effects of verapamil and D600: comparison with propranolol.
    Watanabe AM; Besch HR
    J Pharmacol Exp Ther; 1974 Nov; 191(2):241-51. PubMed ID: 4153724
    [No Abstract]   [Full Text] [Related]  

  • 12. [The nature of differences in beta-adrenergic receptors].
    Abrmets II; Simon IB
    Biull Eksp Biol Med; 1975 May; 79(5):11-4. PubMed ID: 1227580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholinergic antagonism by beta-blockers. II. Sequence of interactions and final steady state effects].
    Re L; Rossini L
    Boll Soc Ital Biol Sper; 1980 May; 56(9):899-904. PubMed ID: 6108774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putrescine modulation of acute activation of the beta-adrenergic system in the left atrium of rat.
    Bordallo C; Cantabrana B; Velasco L; Secades L; Meana C; Méndez M; Bordallo J; Sánchez M
    Eur J Pharmacol; 2008 Nov; 598(1-3):68-74. PubMed ID: 18755180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent effects of postnatal administration of beta-adrenergic ligands on the volume of sexually dimorphic nucleus of the preoptic area (SDN-POA) in rats.
    Izdebska-Straszak G; Gubala E; Jedrzejowska-Szypulka H; Klencki M; Wiczkowski A; Jarzab B
    Neuro Endocrinol Lett; 2006; 27(1-2):105-13. PubMed ID: 16648786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Propranolol beta-blocker decrease in the concentration of high-affinity binding sites for calcium ions by sarcolemma membranes of the rat heart].
    Seleznev IuM; Martynov AV; Smirnov VN
    Biull Eksp Biol Med; 1982 May; 93(5):72-4. PubMed ID: 7093513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylate cyclase and beta adrenergic receptor development in the mouse heart.
    Chen FC; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1982 Jul; 222(1):7-13. PubMed ID: 6283073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
    Bekes M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1972 Aug; 6(3):209-13. PubMed ID: 4405377
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
    Sawutz DG; Sylvestre D; Homcy CJ
    J Immunol; 1985 Oct; 135(4):2713-8. PubMed ID: 2993414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.